BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND JAK3, L-JAK, 3718, ENSG00000105639, P52333, JAKL, JAK-3, LJAK, JAK3_HUMAN AND Treatment
17 results:

  • 1. jak3 Inhibition Regulates Stemness and Thereby Controls Glioblastoma Pathogenesis.
    Smedley W; Patra A
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947625
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Radiotherapy opens the blood-brain barrier and synergizes with anlotinib in treating glioblastoma.
    Li PJ; Lai SZ; Jin T; Ying HJ; Chen YM; Zhang P; Hang QQ; Deng H; Wang L; Feng JG; Chen XZ; Guo P; Chen M; Tian Y; Chen YY
    Radiother Oncol; 2023 Jun; 183():109633. PubMed ID: 36963438
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the jak3-STAT1/PI3K-AKT signaling pathway.
    Chen X; Zhu M; Zou X; Mao Y; Niu J; Jiang J; Dong T; Shi Y; Yang X; Liu P
    Life Sci; 2022 Dec; 311(Pt B):121174. PubMed ID: 36396110
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.
    Zhang F; Zhang Q; Zhu J; Yao B; Ma C; Qiao N; He S; Ye Z; Wang Y; Han R; Feng J; Wang Y; Qin Z; Ma Z; Li K; Zhang Y; Tian S; Chen Z; Tan S; Wu Y; Ran P; Wang Y; Ding C; Zhao Y
    Cell Res; 2022 Dec; 32(12):1047-1067. PubMed ID: 36307579
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effects of Vitexin, a Natural Flavonoid Glycoside, on the Proliferation, Invasion, and Apoptosis of Human U251 Glioblastoma cells.
    Huang J; Zhou Y; Zhong X; Su F; Xu L
    Oxid Med Cell Longev; 2022; 2022():3129155. PubMed ID: 35281458
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.
    Newell F; Pires da Silva I; Johansson PA; Menzies AM; Wilmott JS; Addala V; Carlino MS; Rizos H; Nones K; Edwards JJ; Lakis V; Kazakoff SH; Mukhopadhyay P; Ferguson PM; Leonard C; Koufariotis LT; Wood S; Blank CU; Thompson JF; Spillane AJ; Saw RPM; Shannon KF; Pearson JV; Mann GJ; Hayward NK; Scolyer RA; Waddell N; Long GV
    Cancer Cell; 2022 Jan; 40(1):88-102.e7. PubMed ID: 34951955
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Network Pharmacology Analysis of Molecular Mechanism of Curcuma longa L. Extracts Regulating Glioma Immune Inflammatory Factors: Implications for Precise Cancer treatment.
    Li H; Li Y
    Curr Top Med Chem; 2022 Mar; 22(4):259-267. PubMed ID: 34515002
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Novel CTRP8-RXFP1-jak3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells.
    Glogowska A; Thanasupawat T; Beiko J; Pitz M; Hombach-Klonisch S; Klonisch T
    Mol Oncol; 2022 Jan; 16(2):368-387. PubMed ID: 33960104
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and jak3 mutations.
    Poli R; Scatolini M; Grosso E; Maletta F; Gallo M; Liscia D; Nelva A; Cesario F; Forte G; Metovic J; Volante M; Arvat E; Papotti M
    Endocrine; 2021 Jan; 71(1):216-224. PubMed ID: 32743766
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting Upstream Kinases of STAT3 in Human Medulloblastoma cells.
    Wei J; Ma L; Li C; Pierson CR; Finlay JL; Lin J
    Curr Cancer Drug Targets; 2019; 19(7):571-582. PubMed ID: 30332965
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles.
    Kim JS; Kim MW; Kang SJ; Jeong HY; Park SI; Lee YK; Kim HS; Kim KS; Park YS
    Int J Nanomedicine; 2018; 13():4817-4830. PubMed ID: 30214190
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Primary and secondary mucosal melanoma of the small intestine - a clinical, pathological, and genetic nationwide survey of Danish patients between 1980 and 2014.
    Tingsgaard JK; Henriksen A; Mikkelsen LH; Behrendt N; Melchior LC; Svendsen LB; Heegaard S
    APMIS; 2018 Sep; 126(9):739-745. PubMed ID: 30160023
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
    Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
    BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
    Vollbrecht C; Werner R; Walter RF; Christoph DC; Heukamp LC; Peifer M; Hirsch B; Burbat L; Mairinger T; Schmid KW; Wohlschlaeger J; Mairinger FD
    Br J Cancer; 2015 Dec; 113(12):1704-11. PubMed ID: 26645239
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
    Motoyama K; Onodera R; Tanaka N; Kameyama K; Higashi T; Kariya R; Okada S; Arima H
    Biol Pharm Bull; 2015; 38(3):374-9. PubMed ID: 25757918
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
    Park JI; Strock CJ; Ball DW; Nelkin BD
    Cytokine; 2005 Feb; 29(3):125-34. PubMed ID: 15613280
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line.
    Jackson DP; Watling D; Rogers NC; Banks RE; Kerr IM; Selby PJ; Patel PM
    Melanoma Res; 2003 Jun; 13(3):219-29. PubMed ID: 12777975
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.